Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster

Journal of Dermatology

Volumn 39, Issue 11, 2012, Pages 902-908

  Ono, Fumitake ^a   Yasumoto, Shinichiro ^b   Furumura, Minao ^a   Hamada, Takahiro ^a   Ishii, Norito ^a   Gyotoku, Takashi ^b   Higuchi, Mitsunari ^b   Inokuchi, Kenichiro ^b   Jyo, Kazuo ^b   Koga, Hideaki ^b   Komai, Ayako ^b   Maruta, Koji ^b   Mashiko, Tami ^b   Mihara, Tsukasa ^b   Miyahara, Hiroko ^b   Miyasato, Minoru ^b   Muto, Koichiro ^b   Nagase, Koichi ^b   Nagata, Masakazu ^b   Sakihama, Hideki ^b   Tanahashi, Tomoko ^b   Ueda, Atsuto ^c   Yamakawa, Kyoko ^b   Ohata, Chika ^a   Dainichi, Teruki ^a   Tsuruta, Daisuke ^a   Hashimoto, Takashi ^a   more..

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Yasumoto Skin Clinic ^*  (Japan)

^c Asakura Medical Association Hospital   (Japan)

Author keywords

antiviral therapy; famciclovir efficacy; herpes zoster; immunocompetent patients; zoster associated pain

Indexed keywords

CELECOXIB; FAMCICLOVIR; LOXOPROFEN; NAPROXEN; PARACETAMOL; VALACICLOVIR;

ABSENCE OF SIDE EFFECTS; ADULT; ADVERSE DRUG REACTION; ANALGESIA; ARTICLE; CERVICAL SPINAL CORD; CONTROLLED STUDY; DERMATOME; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOCOMPROMISED PATIENT; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONSET AGE; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL; RASH; SYSTEMIC DULLNESS; THORACIC SPINAL CORD; TREATMENT DURATION; TRIGEMINAL NERVE; VISUAL ANALOG SCALE;

2-AMINOPURINE; ACUTE PAIN; ACYCLOVIR; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIVIRAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HERPES ZOSTER; HUMANS; IMMUNOCOMPETENCE; JAPAN; MALE; MIDDLE AGED; PAIN MEASUREMENT; VALINE;

EID: 84868199828     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2012.01584.x     Document Type: Article

References (11)

1. Johnson RW, Dworkin RH,. Treatment of herpes zoster and postherpetic neuralgia. BMJ 2003; 326: 748-750. (Pubitemid 36408042)
2. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T,. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010; 8: 37.
3. Schmader KE, Sloane R, Pieper C, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 2007; 23: 490-496. (Pubitemid 46956185)
4. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH,. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004; 39: 342-348. (Pubitemid 39050481)
5. Lydick E, Epstein RS, Himmelberger D, White CJ,. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology 1995; 45: S52-S53. (Pubitemid 26163687)
6. Weinke T, Edte A, Schmitt S, Lukas K,. Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: a patient-reported outcomes survey. Z Gesundh Wiss 2010; 18: 367-374.
7. Whitley RJ, Soong SJ, Dolin R, Betts R, Linnemann C Jr, Alford CA Jr,. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med 1982; 307: 971-975. (Pubitemid 12018954)
8. Jung BF, Johnson RW, Griffin DR, Dworkin RH,. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-1551. (Pubitemid 38608193)
9. Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ,. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000; 9: 863-869.
10. Bacon TH, Gilbart J, Howard BA,. Standring-Cox R. Inhibition of varicella-zoster virus by penciclovir in cell culture and mechanism of action. Antivir Chem Chemother 1996; 7: 71-78. (Pubitemid 26092073)
11. Johnson R,. Herpes zoster-predicting and minimizing the impact of post-herpetic neuralgia. J Antimicrob Chemother 2001; 47 (Suppl T1): 1-8. (Pubitemid 32149544)